U.S. Markets closed
  • S&P Futures

    3,694.25
    -14.75 (-0.40%)
     
  • Dow Futures

    29,555.00
    -114.00 (-0.38%)
     
  • Nasdaq Futures

    11,331.00
    -45.75 (-0.40%)
     
  • Russell 2000 Futures

    1,679.00
    -7.10 (-0.42%)
     
  • Crude Oil

    79.12
    +0.38 (+0.48%)
     
  • Gold

    1,650.20
    -5.40 (-0.33%)
     
  • Silver

    18.79
    -0.12 (-0.63%)
     
  • EUR/USD

    0.9682
    -0.0155 (-1.5782%)
     
  • 10-Yr Bond

    3.6970
    -0.0110 (-0.30%)
     
  • Vix

    29.92
    +2.57 (+9.40%)
     
  • GBP/USD

    1.0800
    -0.0455 (-4.0423%)
     
  • USD/JPY

    143.3540
    +1.0190 (+0.7159%)
     
  • BTC-USD

    18,726.67
    -211.33 (-1.12%)
     
  • CMC Crypto 200

    434.61
    -9.92 (-2.23%)
     
  • FTSE 100

    7,018.60
    -140.92 (-1.97%)
     
  • Nikkei 225

    27,153.83
    -159.27 (-0.58%)
     

Atea Pharmaceuticals, Inc. (AVIR) Q2 2022 Earnings Call Transcript

·22 min read
Atea Pharmaceuticals, Inc. (AVIR) Q2 2022 Earnings Call Transcript

With me today from Atea are chief executive officer and founder, Dr. Before we begin the call, as outlined on Slide 2, I would like to remind you that today's discussion will contain forward-looking statements that involve risks and uncertainties.